Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow COR
Cencora, Inc. (COR) Total debt
Cencora, Inc.'s total debt at the end of fiscal 2025 was $7.7B, up 74.6% from $4.4B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $11.7B. Over the past ten years it has ranged from $3.7B (fiscal 2015) to $7.7B (fiscal 2025) — the current reading is the highest in ten years. Cencora, Inc. ranks 2nd of 11 Medical Distribution companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $7.7B | 74.58% |
| FY2024 | $4.4B | (8.34%) |
| FY2023 | $4.8B | (16.05%) |
| FY2022 | $5.7B | (14.68%) |
| FY2021 | $6.7B | 62.25% |
| FY2020 | $4.1B | (8.32%) |
| FY2019 | $4.5B | (3.63%) |
| FY2018 | $4.7B | 22.90% |
| FY2017 | $3.8B | (14.99%) |
| FY2016 | $4.5B | 19.35% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $11.7B | (5.35%) |
| Mar 2026 | $12.4B | 56.35% |
| Dec 2025 | $7.9B | 3.41% |
| Sep 2025 | $7.7B | (7.03%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| MCK McKesson Corporation compare | $14.8B |
| COR Cencora, Inc. | $11.7B |
| CAH Cardinal Health, Inc. compare | $8.9B |
| HSIC Henry Schein, Inc. compare | $2.4B |
| ACH Accendra Health, Inc. compare | $1.7B |
| FOCL FocalTherics compare | $40.1M |
| COSM Cosmos Health Inc. compare | $11.8M |
| AHG Akso Health Group Sponsored ADR compare | $4.6M |
| HKPD Cellyan Biotechnology Co., Ltd compare | $943.3K |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement